The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Debating how to reduce the risk of diabetes

     During the European Association for the Study of Diabetes 2008 Meeting, Dr. Paul Zimmet, who is Director of the International Diabetes Institute in Melbourne, Australia argued for greater reliance on drugs.

    Dr. Nick Wareham, who is Director of the MRC Epidemiology Unit at the University of Cambridge in the UK advocated to control risk factors and support public health solutions.

    Dr. Wareham’s view…

    • Lifestyle changes address the root cause of type 2 diabetes, not its consequences.
    • Drugs have adverse effects.
    • Drugs discourage people from making meaningful lifestyle changes.

    Dr. Zimmet countered…

    • Environmental, cultural, economic, and sociopolitical forces work against lifestyle changes in developed countries.
    • These factors are amplified in other parts of the world.
    • Lifestyle interventions can work, but there’s no way to force people to rigorously control their exercise and diet.

    The bottom line?
    Dr. Zimmet points to preventive genomics — the study of the effect of a person’s genes on the body’s response to medications — as a way that “may prove useful” for identifying individuals who could benefit from lifestyle changes and those in whom pharmacotherapy is appropriate.

    In fact, a test based on pharmacogenomics, that identifies diabetic patients at highest risk of cardiovascular complications recently became available.

    10/1/08 21:21 JR

    Leave a Comment

    You must be logged in to post a comment.